IP Library › Granted Patent US 11,135,241
Granted Patent B2
US 11,135,241 · App. 16/218,683 · Granted Oct 5, 2021

Compositions and methods to affect skin irritation

Inventors: Ronald E. Utecht (Volga, SD); Therese M. Downey (Sioux Falls, SD); Miri Seiberg (Princeton, NJ); Stanley S. Shapiro (Roseland, NJ); Jack V. Foster, Jr. (New Orleans, LA)
Assignees: Alumend, LLC; Wavepharma, LLC
A61K31/737A61F13/8405A61K8/347A61K8/671A61K8/736A61K9/0014A61K31/05A61K31/07A61K31/185A61K31/203A61K31/722A61K45/06A61K47/36A61P17/18A61Q19/08A61K2800/75A61K2800/782
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,135,241
App. No.
16/218,683
Granted
Oct 5, 2021
Kind
B2
Abstract

Compositions are described that contain treated chitosan, modified chitosan and/or modified and treated chitosan for use in formulations for skin, hair and nails, and in compositions and methods of reducing topical agent-induced skin irritation and inflammation.

Claims (12)

1. A composition comprising:

(a) at least one topical irritating agent comprising sodium dodecyl sulfate (SDS) in an amount of 0.04-5% W/V of the total weight of the composition, and

(b) at least one chitosan covalently modified with octane sulfonic acid via sulfonamide linkage (OsC), wherein the OsC is present in an amount of about 0.5-5% W/V of the total weight of the composition, and wherein the composition provides a reduction in skin irritation and/or a reduction in skin inflammation and/or a reduction in the topical irritating agent-induced IL-1α secretion caused by duration of contact between skin and the composition compared with a control composition comprising the topical irritating agent but not the chitosan.

2. The composition of claim 1 , which is in the form of a solution, suspension, emulsion, lotion, cream, gel, stick, spray, ointment, hair conditioner, paste, foam, powder, mousse, solid bar, shaving cream, shaving gel, wipe, patch, hydrogel, or mask.

3. The composition of claim 1 , wherein the OsC comprises about 1-5% W/V of the total weight of the composition.

4. The composition of claim 1 , wherein the OsC comprises about 0.5-3% W/V of the total weight of the composition.

5. The composition of claim 1 , wherein the OsC comprises about 0.5-2% W/V of the total weight of the composition.

6. The composition of claim 1 , wherein the OsC comprises about 1-3% W/V of the total weight of the composition.

7. The composition of claim 1 , wherein the OsC comprises about 1-2% W/V of the total weight of the composition.

8. The composition of claim 1 , wherein the SDS comprises about 0.2-5% W/V of the total weight of the composition.

9. The composition of claim 1 , wherein the SDS comprises about 0.4-5% W/V of the total weight of the composition.

10. The composition of claim 1 , wherein the SDS comprises about 0.6-5% W/V of the total weight of the composition.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 23, 2021
From: SEIBERG, MIRI; SHAPIRO, STANLEY S.; FOSTER, JACK V., JR.
To: WAVEPHARMA, LLC
Reel/Frame 058235/0658 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 23, 2021
From: DOWNEY, THERESE M.; UTECHT, RONALD E.
To: ALUMEND, LLC
Reel/Frame 058235/0711 →
Continuity (4)
Continuation 15830307 · Dec 4, 2017
Continuation 15387138 · Dec 21, 2016
Provisional Application 62271591 · Dec 28, 2015
Related Publication 20190125781A1 · May 2, 2019